79392996 - BDC

Information

• Trademark
• 79392996

• Source

• Serial Number

  79392996

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 19, 2023
  a year ago

• Transaction Date

  December 17, 2024
  10 days ago

• Status Date

  December 16, 2024
  11 days ago

• Location Date

  December 16, 2024
  11 days ago

• Status Code

  661

• Current Location

  INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)

  Employee Name

  ANDREACCHI,SAMANTHA A

• Attorney Docket Number

  601696

  Attorney Name

  Andrew D. Price & Paula E. Hopkins

  Law Office Assigned Location Code

  O30

• Owners

  • BicycleTx Limited

Case File Statements

• GS0051: Pharmaceuticals for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the treatment of cancer; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of oncology; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of ophthalmology; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of neurology; anti-infective pharmaceutical products and preparations for use in preventing and treating infections; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease
• GS0421: Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; medical research services, namely, industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical research services, namely, pharmaceutical testing and clinical trials; scientific research in the nature of conducting clinical trials for others; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; scientific research consulting, namely, providing information consultancy and advisory services relating to the aforesaid in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents

Case File Event Statements

• 4/4/2024 - 8 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 4/12/2024 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/30/2024 - 5 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 7/30/2024 - 5 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 8/17/2024 - 4 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/16/2024 - 11 days ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/16/2024 - 11 days ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/16/2024 - 11 days ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/3/2024 - 5 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/18/2024 - 8 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 7/1/2024 - 5 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/2/2024 - 5 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT